"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper".

Conte P, Ciruelos E, Curigliano G, De Laurentiis M, Del Mastro L, Gennari A, Llombart A, Martìn M, Poggio F, Prat A, Puglisi F, Saura C

Open source

DOI: 10.1016/j.breast.2024.103742
Published: 2024 Aug
Container: Breast (Edinburgh, Scotland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2024.103742,
  title = {"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper".},
  author = {Conte P and Ciruelos E and Curigliano G and De Laurentiis M and Del Mastro L and Gennari A and Llombart A and Martìn M and Poggio F and Prat A and Puglisi F and Saura C},
  year = {2024},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2024.103742},
  url = {https://doi.org/10.1016/j.breast.2024.103742}
}

RIS

TY  - JOUR
TI  - "Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper".
AU  - Conte P
AU  - Ciruelos E
AU  - Curigliano G
AU  - De Laurentiis M
AU  - Del Mastro L
AU  - Gennari A
AU  - Llombart A
AU  - Martìn M
AU  - Poggio F
AU  - Prat A
AU  - Puglisi F
AU  - Saura C
PY  - 2024
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2024.103742
UR  - https://doi.org/10.1016/j.breast.2024.103742
ER  -

APA

P, C., E, C., G, C., M, D. L., L, D. M., A, G., A, L., M, M., F, P., A, P., F, P., & C, S. (2024). "Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper".. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2024.103742

Source records

pubmed · retrieved 2026-09-25T21:01:51.132Z